Scientific Advisory Board

​Founder and CEO

​

Dr Dama is a molecular oncology scientist and translational innovator with over 20 years of experience in cancer research, gene therapy, immunotherapy, and human-relevant preclinical science. She serves as Founder & CEO of NAMina Bio, leading strategic scientific integration across translational partners, AI platforms, and organ-on-chip technologies.

Dr. Dama holds a Master’s degree in Cellular Biology and a Doctorate in Molecular Oncology. Her work bridges rigorous biology, ethical innovation, and clinically relevant translational strategy.

She serves on the editorial boards of Cancer Gene Therapy (Nature Portfolio) and Frontiers in Transplantation, Cell and Stem Cell, and is the founder of Task Force Pandora, a scientific advocacy initiative focused on environmental health and public trust in science.

Scientific Advisory Board Member

RNA Biology & Translational Oncology

Editor-in-Chief, Cancer Gene Therapy (Nature Portfolio)

​

Dr. Leandro Castellano is a molecular biologist specializing in RNA biology and cancer. He obtained his PhD in Human Biology and Genetics from the University of Rome “La Sapienza” and has held academic positions at Imperial College London and the University of Sussex.

He is currently Head of the Department of Biochemistry and Biomedicine and Reader (Associate Professor) in RNA Biology at the University of Sussex, co-Director of the Sussex RNA Research Centre, and holds an honorary position at Imperial College London. His research focuses on microRNAs and non-coding RNAs in epithelial cancer development and progression.

He serves as Editor-in-Chief of Cancer Gene Therapy (Nature Portfolio).